Behind The Labs

Behind The Labs
  • 0.0 (0)
  • Life Sciences
  • Updated Weekly

A podcast where we explore new studies in the world, relating to biological advancements and more, and we also speak to experts on these topics. Get ready to learn more about what goes on Behind The Labs!

  1. 3d ago

    Behind The Labs - Episode 58 - Calorie Tracking Apps Could Be Wrong, New Ozempic-Like Compounds, and Shrooms as a Therapeutic Device?

    In this episode of Behind the Labs, we explore four exciting studies that showcase how advances in artificial intelligence, neuroscience, metabolism, and gene editing are shaping the future of medicine. We discuss new research revealing that popular AI-powered calorie tracking apps significantly underestimate calorie and fat intake, highlighting the importance of using these tools cautiously. We also examine how a single dose of psilocybin may temporarily reshape brain activity, increase psychological insight, and improve well-being, offering new clues about its potential role in treating depression and other mental health disorders. The episode also covers a promising obesity treatment discovered using artificial intelligence—a naturally occurring peptide called BRP that produced Ozempic-like weight loss in animal studies while avoiding many common side effects. We then dive into groundbreaking neuroscience research showing that autism-like symptoms caused by prenatal inflammation in mice could be rapidly improved by targeting brain signaling pathways, suggesting that the adult brain may be more adaptable than previously believed. F

  2. Jul 7

    Behind The Labs - Episode 57 - Alzheimer's Prevention, The Exercise-Muscle Axis, and Sleep's Recovery Mechanism!

    This episode dives into four major discoveries reshaping how scientists understand brain and muscle aging. We start with a Duke-NUS study showing exercise fights age-related muscle loss by correcting a molecular imbalance driven by the gene DEAF1, which disrupts the cell's ability to clear damaged proteins as we age. From there we shift to the brain, exploring a King's College London discovery of "karyoptosis," a newly identified cell death process that may explain how toxic protein buildup kills neurons in Alzheimer's and frontotemporal dementia, pointing to a specific molecular target (p38 MAP kinase and LaminB1) for future therapies. We then turn to sleep, unpacking UC Berkeley research that maps the brain circuitry linking deep sleep to growth hormone release, revealing a feedback loop between hormone levels and the brain's alertness center that helps explain why poor sleep disrupts growth, metabolism, and recovery. Finally, we explore the mystery of cognitive resilience, discussing a Netherlands Institute for Neuroscience study on why some people stay mentally sharp despite Alzheimer's pathology in their brains, with early evidence pointing to rare "immature neurons" that behave differently in resilient individuals, not by growing in number, but by activating survival programs that may help protect surrounding brain tissue. Together, these studies highlight a common thread: aging and disease resistance often come down to how cells manage stress, repair, and communication rather than simple decline.

  3. Jun 24

    Behind The Labs - Episode 56 - Preventing and Reversing Neurodegenerative Diseases and the Physiological-Psychological Connection that Can Help Identify Personalized Medicine and Medication!

    In this episode of Behind The Labs, we broke down five major research studies pushing the boundaries of neuroscience and medicine. We covered Northwestern's experimental drug NU-9, which may prevent Alzheimer's before symptoms ever appear by targeting a newly identified toxic amyloid subtype. We then talked about Japanese researchers engineering a supercharged vitamin K compound that can actually regenerate lost neurons — a first for the field. Johns Hopkins blew our minds with pea-sized lab-grown brains that can distinguish schizophrenia from bipolar disorder with 92% accuracy, opening the door to personalized psychiatric treatment. On the prevention side, a massive meta-analysis confirmed that eating legumes and soy foods daily can cut hypertension risk by nearly 30%, and NYU researchers found a simple blood test that detects depression through accelerated immune cell aging — before you even feel it. The big theme across all of it: medicine is shifting from treating disease after the damage is done to catching and stopping it years earlier.

  4. May 22

    Behind The Labs - Episode 55 - The Brain's Role in Endurance & Stamina, The Cognitive Benefits of Creatine, and Saying Um or Uh Could Point to Future Dementia?

    Today at Behind The Labs, we’re looking at five recent health-related studies that sound very different on the surface: exercise, dementia, Alzheimer’s disease, semaglutide, and creatine. But there’s a common theme across all of them: health is not just about one organ, one habit, or one simple cause. The brain affects endurance. Speech may reveal cognitive decline. Blood vessels may shape Alzheimer’s disease. Weight-loss medication may help older adults but still requires caution. Creatine may support more than muscle.

  5. May 4

    Behind The Labs - Episode 54 - Early Morning Alternative to Caffeine, Challenging Your Brain = Reduced Risk of Alzheimer's, and Pain is a Maintained Neural Process?

    In this episode of Behind the Labs, we explore cutting-edge research that’s reshaping how we understand sleep, brain health, and chronic pain. We start with a clinical trial on solriamfetol, a wake-promoting drug showing promising results for early morning shift workers—a group often overlooked despite facing major circadian rhythm disruptions. The findings highlight how aligning (or misaligning) with our biological clock can dramatically impact alertness, performance, and overall well-being. We also dive into a Lancet-published study on sulthiame, a potential game-changer for obstructive sleep apnea, offering hope for patients who struggle with traditional CPAP therapy by directly improving breathing regulation during sleep. Beyond sleep, we unpack research on lifelong cognitive engagement and its link to reduced Alzheimer’s risk, emphasizing the idea of “cognitive reserve” and how habits like reading and learning may delay neurodegeneration by years. Finally, we discuss groundbreaking neuroscience uncovering a brain circuit in the insular cortex that may actively sustain chronic pain—challenging the notion that pain simply lingers after injury. Together, these studies reveal how deeply interconnected our brain, behavior, and biology are, while pointing toward innovative treatments that could transform patient care in the future.

  6. Apr 22

    Behind The Labs - Episode 53 - The Gene Mutation Behind Deafness, Astrocytes As Memory Regulators, and Completely Revolutionizing the Intracellular Protein Pathway!

    In this episode of Behind the Labs, we explored a series of studies that challenge some of the most fundamental assumptions in biology and medicine. From the brain to the lungs to individual cells, researchers are uncovering active, dynamic systems where we once thought processes were passive. We discussed how astrocytes—long considered mere support cells—actually play a direct role in encoding and controlling fear memories, reshaping how we understand emotional regulation and disorders like PTSD. We also looked at a breakthrough in gene therapy that successfully restored hearing in patients with genetic deafness, highlighting the growing potential of precision medicine to not just manage, but potentially cure sensory disorders. We then turned to aging and disease, examining how changes in lung tissue—not just immune decline—can drive severe outcomes in infections like COVID-19 through runaway inflammation. Finally, we covered a discovery showing that cells actively transport proteins using internal “trade winds,” challenging the classic diffusion model and offering new insight into processes like wound healing and cancer metastasis. Together, these studies paint a picture of biology as far more active, interconnected, and targetable than previously thought—opening the door to entirely new therapeutic strategies.

  7. Mar 17

    Behind The Labs - Episode 52 - Vitamin C Vs. COVID-19, Microplastics Leading to Neurodegenerative Diseases, and Paternal Nicotine Exposure Effects Child Metabolic Health

    In this episode of Behind the Labs, we explore several new studies that reveal how everyday exposures and biological processes can influence human health. We begin with the VIVID clinical trial, which tested whether high-dose vitamin D supplements could reduce the severity of COVID-19 or prevent infection within households. While the study found no meaningful effect on acute illness or transmission, researchers observed a possible small reduction in long-COVID symptoms among participants who closely followed the supplementation regimen. We also discuss research on paternal nicotine exposure, where scientists discovered that nicotine use in fathers before conception altered metabolic pathways in their offspring, suggesting that a father’s health habits may influence the long-term disease risk of future children. The episode then shifts to environmental and neurological health, highlighting a systematic review suggesting that microplastics could contribute to neurodegenerative diseases such as Alzheimer’s and Parkinson’s through mechanisms like inflammation, oxidative stress, and mitochondrial dysfunction. We also cover a study showing that THC intoxication can significantly impair multiple types of memory, including prospective memory and source memory, even at moderate doses. Finally, we examine new research linking cellular energy metabolism to depression, where abnormal ATP production patterns may help explain fatigue and cognitive symptoms in patients, as well as a clinical trial showing that the drug sulthiame may reduce breathing interruptions in obstructive sleep apnea, offering a potential alternative treatment to CPAP machines. Together, these studies highlight how advances in biomedical research continue to uncover unexpected connections between environment, behavior, and disease.

  8. Feb 28

    Behind The Labs - Episode 51 - Cancer Eating Bacteria, Diet-Induced Thermogenesis, and Stem Cell Derived Parkinson's Treatment?

    This week on Behind the Labs, we break down four cutting-edge studies reshaping how we think about metabolism, aging, cancer therapy, and early development. First, researchers show that reducing specific amino acids in the diet can boost thermogenesis and fat burning in mice—without more exercise. Next, a UCLA team reveals why aging muscle stem cells slow down: a survival protein keeps them alive longer but at the cost of repair speed. We also explore an innovative cancer strategy using engineered bacteria to infiltrate and consume oxygen-starved tumor cores, and a promising stem cell trial aiming to restore dopamine-producing neurons in Parkinson’s disease. Finally, new genome-mapping technology overturns the “blank slate” model of early embryos, showing DNA is highly organized far earlier than scientists thought. Together, these studies highlight a common theme in modern biology: powerful trade-offs underlie many of the body’s most important systems.

See All (59)

About

A podcast where we explore new studies in the world, relating to biological advancements and more, and we also speak to experts on these topics. Get ready to learn more about what goes on Behind The Labs!

Information

  • Creator
    Behind The Labs
  • Years Active
    2024 - 2026
  • Episodes
    59
  • Rating
    Clean
  • Copyright
    © Behind The Labs
  • Show Website
    Behind The Labs